Search Results - "Pérez‐Blanco, Jonás Samuel"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia by Corral Alaejos, Álvaro, Zarzuelo Castañeda, Aránzazu, Jiménez Cabrera, Silvia, Sánchez‐Guijo, Fermín, Otero, María José, PérezBlanco, Jonás Samuel

    Published in British journal of clinical pharmacology (01-02-2022)
    “…Aims Imatinib is considered the standard first‐line treatment in newly diagnosed patients with chronic‐phase myeloid leukaemia (CML). Several imatinib…”
    Get full text
    Journal Article
  2. 2

    Model-Informed Precision Dosing (MIPD) by Pérez-Blanco, Jonás Samuel, Lanao, José M

    Published in Pharmaceutics (01-12-2022)
    “…Model-informed precision dosing (MIPD) is an advanced quantitative approach focusing on individualized dosage optimization, integrating complex mathematical…”
    Get full text
    Journal Article
  3. 3

    Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects by Pérez-Ruixo, Carlos, Pérez-Blanco, Jonás Samuel, Chien, Caly, Yu, Margaret, Ouellet, Daniele, Pérez-Ruixo, Juan-José, Ackaert, Oliver

    Published in Clinical pharmacokinetics (01-02-2020)
    “…Background Apalutamide is a next-generation androgen receptor inhibitor approved for treatment of subjects with high-risk, non-metastatic, castration-resistant…”
    Get full text
    Journal Article
  4. 4

    Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK by Zazo, Hinojal, Lagarejos, Eduardo, Prado-Velasco, Manuel, Sánchez-Herrero, Sergio, Serna, Jenifer, Rueda-Ferreiro, Almudena, Martín-Suárez, Ana, Calvo, M Victoria, Pérez-Blanco, Jonás Samuel, Lanao, José M

    Published in Frontiers in pharmacology (28-09-2022)
    “…Each year, infections caused around the 25% of neonatal deaths. Early empirical treatments help to reduce this mortality, although optimized dosing regimens…”
    Get full text
    Journal Article
  5. 5

    Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non‐Hodgkin's lymphoma by PérezBlanco, Jonás Samuel, Santos‐Buelga, Dolores, Fernández de Gatta, María del Mar, Hernández‐Rivas, Jesús María, Martín, Alejandro, García, María José

    Published in British journal of clinical pharmacology (01-12-2016)
    “…Aims The aims of the study were: (i) to characterize the pharmacokinetics (PK) of doxorubicin (DOX) and doxorubicinol (DOXol) in patients diagnosed with…”
    Get full text
    Journal Article
  6. 6

    Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients by Teixeira-da-Silva, Paulo, Pérez-Blanco, Jonás Samuel, Santos-Buelga, Dolores, Otero, María José, García, María José

    Published in Pharmaceutics (07-04-2022)
    “…(1) Background: The aim of this study was to explore the valproic acid (VPA) pharmacokinetic characteristics in a large population of pediatric and adult…”
    Get full text
    Journal Article
  7. 7

    Usalpharma: A Cloud-Based Architecture to Support Quality Assurance Training Processes in Health Area Using Virtual Worlds by Martín-Suárez, Ana, Pérez-Blanco, Jonás Samuel, Maderuelo, Cristina, Cruz-Benito, Juan, García-Peñalvo, Francisco J.

    Published in TheScientificWorld (01-01-2014)
    “…This paper discusses how cloud-based architectures can extend and enhance the functionality of the training environments based on virtual worlds and how, from…”
    Get full text
    Journal Article
  8. 8

    Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel disease by Sánchez-Hernández, José Germán, Pérez-Blanco, Jonás Samuel, Rebollo, Noemí, Muñoz, Fernando, Prieto, Vanessa, Calvo, María Victoria

    “…Inflammatory bowel disease (IBD) is commonly treated with adalimumab. The main objective of the study was to develop a population pharmacokinetic model of…”
    Get full text
    Journal Article
  9. 9

    Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin by Pérez-Blanco, Jonás Samuel, Sáez Fernández, Eva María, Calvo, María Victoria, Lanao, José M, Martín-Suárez, Ana

    Published in Pharmaceutics (15-02-2021)
    “…This study aimed to evaluate the potential efficacy and safety of the amikacin dosage proposed by the main guidelines and to develop an interactive nomogram,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients by Peña-Lorenzo, Diego, Rebollo, Noemí, Sánchez-Hernández, José Germán, Zarzuelo-Castañeda, Aránzazu, Vázquez-López, Lourdes, Otero, María José, Pérez-Blanco, Jonás Samuel

    “…•A popPK model of posaconazole tablets in allogeneic SCT adult recipients is presented.•Gender and serum proteins showed a significant impact on posaconazole…”
    Get full text
    Journal Article
  12. 12

    Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach by Pérez-Blanco, Jonás Samuel, Sáez Fernández, Eva María, Calvo, M Victoria, Lanao, José M, Martín-Suárez, Ana

    Published in Journal of antimicrobial chemotherapy (01-08-2020)
    “…To characterize amikacin population pharmacokinetics in patients with hypoalbuminaemia and to develop a model-based interactive application for amikacin…”
    Get full text
    Journal Article
  13. 13

    Evaluation of renal function equations to predict amikacin clearance by Sáez Fernández, Eva María, Pérez-Blanco, Jonás Samuel, Lanao, José M, Calvo, M Victoria, Martín-Suárez, Ana

    Published in Expert review of clinical pharmacology (03-08-2019)
    “…: To evaluate the predictive performance of eight renal function equations to describe amikacin elimination in a large standard population with a wide range of…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Usalpharma: A Software Architecture to Support Learning in Virtual Worlds by Cruz-Benito, Juan, Maderuelo, Cristina, Garcia-Penalvo, Francisco Jose, Theron, Roberto, Perez-Blanco, Jonas Samuel, Gomez, Hinojal Zazo, Martin-Suarez, Ana

    Published in IEEE-RITA (01-08-2016)
    “…This paper explains how a software architecture was planned, designed, and implemented to help in the support of eLearning activities within a virtual…”
    Get full text
    Journal Article
  16. 16

    Monitoring and feedback of learning processes in virtual worlds through analytics architectures: A real case by Cruz-Benito, Juan, Therón, Roberto, García-Peñalvo, Francisco J., Maderuelo, Cristina, Pérez-Blanco, Jonás Samuel, Zazo, Hinojal, Martín-Suárez, Ana

    “…The application of techniques related to Learning Analytics, including the recovery and processing of data and evidences related with the learning tasks, might…”
    Get full text
    Conference Proceeding
  17. 17

    Using software architectures to retrieve interaction information in eLearning environments by Cruz Benito, Juan, Garcia-Penalvo, Francisco J., Theron, Roberto, Maderuelo, Cristina, Perez-Blanco, Jonas Samuel, Zazo, Hinojal, Martin-Suarez, Ana

    “…This research paper presents a software architecture based on services and deployed in a cloud environment that retrieves, analyzes and presents information…”
    Get full text
    Conference Proceeding